Presentations

Documents

Order by : Name | Date | Hits [ Ascendant ]

NASH Therapeutics: Targets Under Evaluation in Early Phase Trials NASH Therapeutics: Targets Under Evaluation in Early Phase Trials

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 428

Oral presentation given by UNEW at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017

Why Should We Care About NAFLD? Why Should We Care About NAFLD?

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 413

Oral presentation given by UNEW at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017

The European NAFLD registry The European NAFLD registry

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 453

Oral presentation given by UNEW at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017

Adipose tissue expandability, Lipotoxicity and the Metabolic Syndrome Adipose tissue expandability, Lipotoxicity and the Metabolic Syndrome

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 5.58 MB
Downloads: 347

Oral presentation given by UCAM at the 19th European Congress of Endocrinology (ECE), Satellite Symposium (Aegerion Pharmaceuticals), Lisbon, Portugal, 20th - 23rd May 2017

Hepatic lipotoxicity and mitochondrial dysfunction: impact of adipose tissue inflammation and... Hepatic lipotoxicity and mitochondrial dysfunction: impact of adipose tissue inflammation and...

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 388

"Hepatic lipotoxicity and mitochondrial dysfunction: impact of adipose tissue inflammation and insulin resistance"

Oral presentation given by CNR at the 51st European Society for Clinical Investigation (ESCI) conference, Genoa, Italy, 17th - 19th May 2017

Metabolic syndrome and NAFLD Metabolic syndrome and NAFLD

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 391

Oral presentation given by CNR at the Tuscan Hepatologists meeting, Italy, 10th - 11th May 2017

Serum phosphatidylglycerols (PG) are correlated with human obesity, gut dysbiosis, and are induced.. Serum phosphatidylglycerols (PG) are correlated with human obesity, gut dysbiosis, and are induced..

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 396

"Serum phosphatidylglycerols (PG) are correlated with human obesity, gut dysbiosis, and are induced by endotoxin"

Poster presentation given by ICAN at the Keystone Symposium “Gastrointestinal Control of Metabolism”, Copenhagen, Denmark, 9th - 13th May 2017

Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin... Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin...

hot!
Date added: 03/13/2018
Date modified: 03/13/2018
Filesize: 256 Bytes
Downloads: 537

"Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin Resistance and Liver Histology in Patients with NASH"

Oral presentation given by CNR at the 5th EASD-NAFLD Study Group meeting, Gothenburg, Sweden, 8th - 9th May 2017

The role of genetic assessments in Non-Alcoholic Fatty Liver Disease The role of genetic assessments in Non-Alcoholic Fatty Liver Disease

hot!
Date added: 03/13/2018
Date modified: 03/13/2018
Filesize: 6.91 MB
Downloads: 573

Oral presentation given by UNEW at the 2nd International Workshop on NASH Biomarkers, Washington DC, USA, 5th - 6th May 2017

Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin... Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin...

hot!
Date added: 03/13/2018
Date modified: 03/13/2018
Filesize: 256 Bytes
Downloads: 469

"Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin Resistance and Liver Histology in Patients with NASH"

Oral presentation given by CNR at the European Group for the study of Insulin Resistance (EGIR) meeting, Dublin, Ireland, 4th - 6th May 2017